ArticleBlood advances2019

Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy.

Joshua A Hill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.